RE: A placing here was obvious13 May 2020 15:24
Agreed, they are all at it, all the pharma shares, GRD just a couple of weeks back, the price plummets for a time
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to announce that it has raised £2,029,250 (£1,907,495 net of expenses) through an oversubscribed placing of 50,731,250 new ordinary shares of 0.4p each in the Company (the "Placing Shares") at an issue price of £0.04 per Placing Share (the "Placing").